Renal InfarctNCT06515379
Emergency Department Management of Patients With Renal Infarction
An observational study of Renal Infarct and Renal Infarction - Venous, run by Saglik Bilimleri Universitesi at 1 site in Turkey (Türkiye).
Trial summary
The aim of this study is to investigate laboratory parameters from medical records of patients diagnosed with renal infarction in our emergency clinic to establish early diagnostic indicators. Read more about this study
- Who is it for?
- Ages 18 to 85 years
- Conditions the study is for
- Renal Infarct, Renal Infarction - Venous, Renal Infarction - Arterial
- How many people
- 80 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 15 Feb 2024to 15 May 2024
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 85 years
- All sexes
- Adult, Older adult
Study population: patients administered to emergency department and diagnosed with renal infarction will be retrospectively determined from hospital data system.
Who may be able to join
- Adult patients aged 18 years and older Cases diagnosed with renal infarction presenting to the Emergency Department of Dışkapı Yıldırım Beyazıt Training and Research Hospital
Who cannot join
- Patients without imaging methods Patients with incomplete laboratory and file follow-ups Patients previously diagnosed with renal infarction and currently under treatment Patients diagnosed with other clinical conditions such as pyelonephritis, lower urinary tract infections, nephrolithiasis
Trial locations and contacts
1 site in 1 country.
Turkey (Türkiye)1 site
Diskapi Teaching and Research Hospital
Ankara, Altindag, 06110
About this study
The aim of this study is to investigate laboratory parameters from medical records of patients diagnosed with renal infarction in our emergency clinic to establish early diagnostic indicators. Additionally, we will evaluate imaging methods such as CT or CT angiography and identify mortality-morbidity markers to contribute to the literature.
Read the detailed description
It is planned to include 80 patients who presented to the hospital emergency department and were diagnosed with renal infarction between January 1, 2014, and June 1, 2023, in the study.
he data of patients diagnosed with renal infarction will be retrospectively collected from the hospital database and recorded in a data collection form. This includes information such as CBC (complete blood count), neutrophils, lymphocytes, platelets, lactate, anion gap, pH, bicarbonate, creatinine, urea, AST, ALT, fibrinogen, D-dimer, LDH, CRP, CT scan, and CT angiography results. Patients' demographic characteristics, physical examination findings, imaging, and laboratory results will be evaluated using patient records and the hospital registry system.
Our aim is to identify early morbidity and mortality indicators in cases of renal infarction where diagnosis is often delayed or missed, contributing to the survival of patients. We believe that the findings from our statistical analysis can guide routine practice, especially in the management of patients presenting to the emergency department with complaints of abdominal and/or flank pain
- Keywords
- Renal Infarction, Emergency Department
- Medical subject headings
- Emergencies
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Renal Infarction | Patients diagnosed with renal infarction using data obtained from the hospital system have been reviewed and evaluated. Laboratory, clinical and imaging data ahve been registered and statistical analyses have been conducted |
What is being measured
The primary outcome is the main question the study is designed to answer.
Renal Infarction
patients diagnosed with renal infarction
Measured: 9 years
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted23 Jul 2024
- Study start15 Feb 2024
- Primary completion15 May 2024
- Study completion15 May 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (3)Papers the sponsor has linked to this study.
- Other trials for Renal InfarctStudies of the same condition, open and under way.
- More trials run by Saglik Bilimleri UniversitesiThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Retrospective
- Enrolment
- 80 participants (actual)
Sponsor and investigators
- Lead sponsor
- Saglik Bilimleri Universitesi
- Sponsor type
- University, hospital or other
- Collaborators
- Diskapi Teaching and Research Hospital
- Responsible party
- Sponsor
- Investigators
- gulsen akcay, ass. prof., Study director, ass. prof. of organization
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06515379
- Sponsor's protocol ID
- RENAL INFARCTION
- Status last verified
- Jul 2024
- First submitted
- 17 Jul 2024
- Last updated
- 23 Jul 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Delezire A, Terrasse M, Bouet J, Laot M, Brun V, Oger E, Vigneau C. Acute renal infarction: long-term renal outcome and prognostic factors. J Nephrol. 2021 Oct;34(5):1501-1509. doi: 10.1007/s40620-020-00953-4. Epub 2021 Mar 25.
PubMed 33765299Francisco D, Pimenta G, Martins AC, Laranjinha I, Estibeiro H, Gil C, Goncalves M, Gaspar MA. Recovering from a renal vascular catastrophe: Case report. Clin Nephrol Case Stud. 2023 Mar 5;11:44-49. doi: 10.5414/CNCS110984. eCollection 2023.
PubMed 36896140Woo S, Lee CA, Lee JW, Moon J, Cho YS, Nah S, Han S. Predictors for Distinguishing Renal Infarction From Urolithiasis in the Emergency Department: A Randomly Matched Retrospective Case-Control Study. J Emerg Med. 2023 Jan;64(1):31-39. doi: 10.1016/j.jemermed.2022.10.009. Epub 2023 Jan 12.
PubMed 36641258
Study at a glance
From the registry record, last updated by the sponsor on 23 Jul 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Emergency Department Management of Patients With Renal Infarction
- ClinicalTrials.gov ID
- NCT06515379
- Acronym / sponsor ID
- RENAL INFARCTION
- Keywords
- Renal Infarction, Emergency Department
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 80 participants (actual)
- Lead sponsor
- Saglik Bilimleri UniversitesiUniversity, hospital or other
- Collaborators
- Diskapi Teaching and Research Hospital
- Study start
- 15 Feb 2024 (actual)
- Primary completion
- 15 May 2024 (actual)
- Study completion
- 15 May 2024 (actual)
- First posted
- 23 Jul 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The aim of this study is to investigate laboratory parameters from medical records of patients diagnosed with renal infarction in our emergency clinic to establish early diagnostic indicators. Additionally, we will evaluate imaging methods such as CT or CT angiography and identify mortality-morbidity markers to contribute to the literature.
Detailed description
It is planned to include 80 patients who presented to the hospital emergency department and were diagnosed with renal infarction between January 1, 2014, and June 1, 2023, in the study.
he data of patients diagnosed with renal infarction will be retrospectively collected from the hospital database and recorded in a data collection form. This includes information such as CBC (complete blood count), neutrophils, lymphocytes, platelets, lactate, anion gap, pH, bicarbonate, creatinine, urea, AST, ALT, fibrinogen, D-dimer, LDH, CRP, CT scan, and CT angiography results. Patients' demographic characteristics, physical examination findings, imaging, and laboratory results will be evaluated using patient records and the hospital registry system.
Our aim is to identify early morbidity and mortality indicators in cases of renal infarction where diagnosis is often delayed or missed, contributing to the survival of patients. We believe that the findings from our statistical analysis can guide routine practice, especially in the management of patients presenting to the emergency department with complaints of abdominal and/or flank pain
Study design
- Observational model
- Cohort
- Time perspective
- Retrospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Renal Infarction | – | –Patients diagnosed with renal infarction using data obtained from the hospital system have been reviewed and evaluated. Laboratory, clinical and imaging data ahve been registered and statistical analyses have been conducted |
Who may qualify
- Ages
- 18 to 85 years
- Sex
- All
- Age groups
- Adult, Older adult
- Study population
- patients administered to emergency department and diagnosed with renal infarction will be retrospectively determined from hospital data system.
Key inclusion criteria (1 listed)
- Adult patients aged 18 years and older Cases diagnosed with renal infarction presenting to the Emergency Department of Dışkapı Yıldırım Beyazıt Training and Research Hospital
Key exclusion criteria (1 listed)
- Patients without imaging methods Patients with incomplete laboratory and file follow-ups Patients previously diagnosed with renal infarction and currently under treatment Patients diagnosed with other clinical conditions such as pyelonephritis, lower urinary tract infections, nephrolithiasis
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Renal Infarction
Time frame: 9 years
patients diagnosed with renal infarction
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 23 Jul 2024.
- Background: PubMed 33765299Delezire A, Terrasse M, Bouet J, Laot M, Brun V, Oger E, Vigneau C. Acute renal infarction: long-term renal outcome and prognostic factors. J Nephrol. 2021 Oct;34(5):1501-1509. doi: 10.1007/s40620-020-00953-4. Epub 2021 Mar 25.
- Background: PubMed 36896140Francisco D, Pimenta G, Martins AC, Laranjinha I, Estibeiro H, Gil C, Goncalves M, Gaspar MA. Recovering from a renal vascular catastrophe: Case report. Clin Nephrol Case Stud. 2023 Mar 5;11:44-49. doi: 10.5414/CNCS110984. eCollection 2023.
- Background: PubMed 36641258Woo S, Lee CA, Lee JW, Moon J, Cho YS, Nah S, Han S. Predictors for Distinguishing Renal Infarction From Urolithiasis in the Emergency Department: A Randomly Matched Retrospective Case-Control Study. J Emerg Med. 2023 Jan;64(1):31-39. doi: 10.1016/j.jemermed.2022.10.009. Epub 2023 Jan 12.
- Individual participant dataSharing planned: No
Related trials for Renal Infarct
Active, not recruitingObservational study
A Longitudinal Cohort Study to Evaluate Cardiovascular Risk Factors and Disease in Haiti
Hypertension, Diabetes
Not yet recruitingPhase 4
Capital Offload-Shock
Hypervolemia, Cardiogenic Shock
Active, not recruitingPhase 3
The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)
Atherosclerotic Cardiovascular Disease (ASCVD), Chronic Kidney Disease (CKD)
Recruiting
NMR Metabolomics-Based Risk Assessment and Stratified Digital Health Interventions in Middle-Aged Adults (PREMAP)
Type 2 Diabetes, Coronary Heart Disease
Not yet recruitingObservational study
High-Sensitivity Troponin T Kinetics and 30-Day Outcomes After Major Abdominal Surgery (TROP-MAS)
Myocardial Infarction (MI), Perioperative Myocardial Injury
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
gulsen akcay, ass. prof. study director
ass. prof. of organization
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Renal Infarct and Renal Infarction - Venous, run by Saglik Bilimleri Universitesi at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 23 Jul 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Renal Infarction (time frame: 9 years). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06515379, which also lists 3 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Jul 2024.